Hypervascular Tumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Of Amber Peripheral Liquid Embolic System (NCT06456125) | LVD Biotech S.L | 2024-06-12 |
Track Hypervascular Tumor automatically
Every clearance here is in the API, with alerts when new ones post.